SCHEMBL30830658

SCHEMBL30830658

CN1C[C@H](Nc2cnn(C)c(=O)c2Br)C[C@H](c2ccc(C(=O)N3CCC4(CC3)CCN(c3ccc(C5CCC(=O)NC5=O)cc3F)CC4)cc2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KAT2B Q92831 10/20 0.47
▸ BRD9 Q9H8M2 3/20 0.47
▸ BRD1 O95696 1/20 0.47
▸ ACHE P22303 1/20 0.47
▸ BRPF1 P55201 1/20 0.47
▸ BPTF Q12830 1/20 0.47
▸ KAT2A Q92830 1/20 0.47
▸ BRD7 Q9NPI1 1/20 0.47
▸ BAZ2B Q9UIF8 1/20 0.47
▸ BRPF3 Q9ULD4 1/20 0.47
▸ CRBN Q96SW2 3/20 0.34
▸ IKZF3 Q9UKT9 1/20 0.34
▸ ALDH1A1 P00352 5/20 0.33
▸ HPGD P15428 2/20 0.33
▸ MAPT P10636 2/20 0.32
▸ TSHR P16473 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ DDB1 Q16531 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30831025 0.93 KAT2B (0.48) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830810 0.93 KAT2B (0.38) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30831073 0.93 KAT2B (0.47) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830963 0.92 KAT2B (0.46) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830929 0.92 KAT2B (0.45) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30831061 0.92 KAT2B (0.46) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30831109 0.91 KAT2B (0.44) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830603 0.90 KAT2B (0.51) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30831002 0.90 KAT2B (0.51) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830728 0.90 KAT2B (0.51) KAT2BBRD9BRD1ACHEBRPF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback